MedTrace Logo

Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids

NCT02298452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2016-05-03

No results posted yet for this study

Summary

The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and functions.

Conditions

  • Hearing Loss, Bilateral or Unilateral

Interventions

DEVICE

Hearing aid.

The hearing aid will be fitted to the individual hearing loss of the subject.

Sponsors & Collaborators

  • Phonak AG, Switzerland

    lead INDUSTRY

Principal Investigators

  • Simone Ebbing, B. Sc. · Phonak AG

Study Design

Allocation
NA
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02298452 on ClinicalTrials.gov